Document is current
Any future updates will be listed below
-
Authors
Leekha, Ankita
Saeedi, Arash
Sefat, K M Samiur Rahman
Kumar, Monish
Martinez-Paniagua, Melisa
Damian, Adrian
Kulkarni, Rohan
Reichel, Kate
Rezvan, Ali
Masoumi, Shalaleh
Liu, Xinli
Cooper, Laurence J. N.
Sebastian, Manu
Sands, Courtney M.
Das, Vallabh E.
Patel, Nimesh B.
Hurst, Brett http://orcid.org/0000-0003-1025-5878
Varadarajan, Navin http://orcid.org/0000-0001-7524-8228
- License Information
-
More Information
Article History
Received: 1 August 2023
Accepted: 1 July 2024
First Online: 23 July 2024
Competing interests
: UH has filed a provisional patent based on the findings of this study. N.V. and L.J.N.C. are co-founders of AuraVax Therapeutics and CellChorus. The remaining authors declare no competing interests.
: The mouse, hamster, and NHP studies were performed under the study protocol (PROTO2020000019, PROTO202100006, PROTO202100049, PROTO202200025), as approved by the Institutional Animal Care and Use Committee in University of Houston. The animal experiments at USU were conducted in accordance with an approved protocol by the Institutional Animal Care and Use Committee of Utah State University. The work was performed in the AAALAC-accredited LARC of the university in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (8th edition; 2011).
